BAYN.DE is trading 19% up at $47.00 after a landmark U.S. Supreme Court decision sharply reduced its Roundup legal overhang.
- The Court ruled 7–2 that federal pesticide law preempts many state failure-to-warn lawsuits, shielding the company from tens of thousands of cancer-warning claims.
- The decision reverses a prior $1.25 million verdict and is expected to lead to the dismissal of current warning-based litigation, according to Bayer.